The present invention relates to a method for forming osseous tissue in any bone tissue site of reduced metabolic state, comprising implanting particles of bioactive glass in a size range of from about 200 micrometers to about 300 micrometers. The particles are made from about 40 % to about 58 % silicon dioxide, from about 10 % to about 30 % sodium oxide, from about 10 % to about 30 % calcium oxide, and up to about 10 % phosphorous pentoxide, by weight.
展开▼